Monday, September 17, 2018 10:20:48 PM
Now, do you find that these vague Press Releases are kind of odd? We now have two unknown Technology Outsourced Vendors. To get maximum impact, most companies would announce these Partnerships jointly. Especially, knowing how the Telecom Game is played, who you hop in bed with is just as important as what you are bringing to the table via a new product or service.
Oh and then there was that so called Patent Press Release claiming they believe its getting granted. Well its now close to 30 days from that P/R. Its not that long to get the Official Patent if they actually were given a greenlight via the USPTO. I however doubt this thing was even filed or it has been rejected.
Here is the other thing, Design Engineers need Data Sheets so that effective choices can be made about a product and its use within a combined solution. There isnt any info from their website nor anything from their Social Media via Facebook or Twitter.
3rd Qtr closes in 2 weeks, so we wont even have a good understanding of the Burn Rates and other Financial Numbers till Mid November. How much they are spending is a critical component considering ARCI appears to have negative working capital among other things. 2nd Qtr, they had yet to do their Intangibles Market Value Assessment. My guess they will delay this so that nobody sees it till sometime next year when they file their 10K.
I can only imagine the Geotraq CTO is going to get burnt out on this. They are Shooting the Moon here. So the quality of who these two Outsourcers are is absolutely critical. I still suspect we will see a suspect "Patsy" Deal from some unknown customer lined up to buy a large quantity of whatever they are allegedly building. They wil need this sooner or later to keep the hype up.
This Share Price still appears to me like trading amongst the Issacs and their Cronies.
Recent JAN News
- JanOne Regains Compliance with Nasdaq's Listing Requirements • PR Newswire (US) • 03/15/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:22:34 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/09/2024 05:36:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:07:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:28:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:33:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/22/2023 09:00:42 PM
- JanOne to Present at the Dawson James 8th Annual Investment Conference • PR Newswire (US) • 09/21/2023 03:30:00 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:33:01 PM
- JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference • PR Newswire (US) • 08/31/2023 05:30:00 PM
- JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain • PR Newswire (US) • 08/29/2023 05:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2023 09:20:13 PM
- JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting • PR Newswire (US) • 08/25/2023 06:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 08/24/2023 08:30:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:33:11 PM
- JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 08/22/2023 09:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/22/2023 04:54:17 PM
- JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 08/18/2023 11:00:00 PM
- JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting • PR Newswire (US) • 08/18/2023 04:42:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/16/2023 07:55:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 08:39:17 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/07/2023 08:19:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 08:24:10 PM
- JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain • PR Newswire (US) • 06/28/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM